Joseph M. Palumbo

Joseph M. Palumbo, MD, LFAPA, MACPsych, is Executive Vice President, Head of Research and Development, and Chief Medical Officer at BioVie. He is a physician-scientist and biopharmaceutical executive with experience spanning academic medicine, clinical research, biotechnology, and multinational pharmaceutical R&D. His work has focused on translating neuroscience and biomarker findings into clinical-development strategies for neurodegenerative, neuropsychiatric, and neurodevelopmental disorders. At BioVie, Dr. Palumbo leads the development of bezisterim in Parkinson’s disease, Alzheimer’s disease, and the neurological manifestations of Long COVID. He previously held senior leadership positions at Zynerba Pharmaceuticals, Mitsubishi Tanabe Pharma, and Johnson & Johnson, where he served as Global Head of Psychiatry and Interim Head of Global Neuroscience. A Yale-trained psychiatrist and former NIH/NIMH research fellow, Dr. Palumbo has held academic appointments at Yale, Cornell, a